Skip to content
Clinical Trials – home
BulgariaBack to Bulgaria

Clinical trials in Dupnitsa – page 5

57 clinical trials in Dupnitsa, Bulgaria. Every trial is listed in the EU Clinical Trials Register and updated daily.

Dupnitsa at a glance
57
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

57 trials in Dupnitsa

Open in trial search

Study of tozorakimab effectiveness and safety in former smokers with Chronic Obstructive Pulmonary Disease (COPD) who experience disease flare-ups

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol
  • Sponsor:AstraZeneca AB

Schizophrenia

Not recruiting

Long-term safety study of trospium chloride and xanomeline tartrate combination (KarXT) in patients with inadequately controlled schizophrenia symptoms

InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Karuna Therapeutics Inc.

Asthma

Not recruiting

Study on the Effectiveness and Safety of Budesonide, Glycopyrronium, and Formoterol Inhaler for Adults and Adolescents with Severe Asthma Not Well Controlled

Registered drug
Countries:BulgariaBulgaria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:AstraZeneca AB

Vitiligo

Not recruiting

Study on the Safety and Effectiveness of Ritlecitinib in Adults and Adolescents with Nonsegmental Vitiligo

Registered drug
Countries:BulgariaBulgaria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Pfizer Inc.

Dermatitis atopic

Not recruiting

Study on the Effectiveness and Safety of Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis Using Topical Corticosteroids

Registered drug
Countries:BulgariaBulgaria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Amlitelimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Schizophrenia

Not recruiting

Study of KarXT (trospium chloride and xanomeline tartrate) in patients with inadequately controlled schizophrenia symptoms

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Karuna Therapeutics Inc.

Asthma

Not recruiting

Study on the Long-term Effects of Dupilumab in Preventing Lung Function Decline in Adults with Uncontrolled Moderate to Severe Asthma

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Dupilumab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Asthma

Not recruiting

Study on the Effectiveness and Safety of Tanimilast for Patients with Uncontrolled Asthma on Inhaled Corticosteroid and Long-Acting Beta2-Agonist Therapy

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Tanimilast
  • Sponsor:Chiesi Farmaceutici S.p.A.

Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen Cilag International

Other cities in Bulgaria

The busiest research cities in the country

All 53 cities in Bulgaria

Clinical research in Dupnitsa

What the registry says about research in the country

01 Cardiovascular & Metabolic Research

Innovative trials focusing on cardiovascular health and metabolic conditions, including studies of new treatments for obesity and heart conditions. Research aims to evaluate therapies for reducing cardiovascular risks and managing weight-related health issues.

  • Obesity and Weight Management
  • Heart Failure
  • Hypertriglyceridemia

Current studies are examining novel compounds for cardiovascular safety and weight reduction outcomes.

02 Respiratory Medicine

Advanced research in respiratory diseases, particularly focusing on chronic conditions affecting lung function. Studies evaluate new treatment combinations and their impact on patient outcomes.

  • Asthma Management
  • COPD Treatment
  • Lung Function Preservation

Trials are investigating innovative therapies to prevent lung function decline and manage exacerbations.

03 Dermatology Studies

Comprehensive research in dermatological conditions, investigating new treatments for various skin disorders. Studies focus on both chronic and acute skin conditions.

  • Atopic Dermatitis
  • Plaque Psoriasis
  • Vitiligo Treatment

Evaluating long-term safety and efficacy of novel therapeutic approaches for skin disorders.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.